论文部分内容阅读
[目的]观察稳心颗粒联合依那普利、辛伐他汀治疗冠心病快速性心房纤颤疗效。[方法]将62例患者分为对照组34例和治疗组28例。对照组患者给予依那普利10mg/d bid,辛伐他汀10mg/d qn;治疗组在对照组的基础上加用稳心颗粒9g/d tid治疗。两组均以14d为1疗程,治疗1疗程后观察心率的下降。[结果]治疗组总有效率优于对照组(P<0.05)。治疗组用药前心率145次/min,用药后心率降至98次/min,对照组用药前心率140次/min,用药后心率110次/min,治疗组优于对照组(P<0.01)。[结论]稳心颗粒联合依那普利、辛伐他汀治疗冠心病快速性心房纤颤的效果明显,值得在临床上推广应用。
[Objective] To observe the curative effect of Wenxin Granule combined with enalapril and simvastatin on patients with rapid atrial fibrillation of coronary heart disease. [Methods] 62 patients were divided into control group 34 cases and treatment group 28 cases. Patients in the control group were given enalapril 10 mg / d bid and simvastatin 10 mg / d qn. The treatment group was treated with Wenxin Granule 9g / d tid on the basis of the control group. Both groups were 14d for a course of treatment, treatment of a course of observation after the decline in heart rate. [Results] The total effective rate in the treatment group was better than that in the control group (P <0.05). The heart rate of the treatment group before treatment was 145 beats / min. After treatment, the heart rate was reduced to 98 beats / min. The control group had a heart rate of 140 beats / min before treatment and a heart rate of 110 beats / min after treatment. [Conclusion] Wenshen granules combined with enalapril and simvastatin has obvious effect in treating rapid atrial fibrillation of coronary heart disease, which is worth popularizing in clinic.